Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NC-005 is a preclinical-stage microbiome-based therapeutic being developed by NodCure for the treatment of skin conditions. As a microbial or probiotic therapy, it likely utilizes specific bacterial strains or consortia to modulate the skin microbiome and restore healthy skin barrier function or immune homeostasis. NodCure focuses on developing microbiome-derived treatments for various dermatological indications, including atopic dermatitis and psoriasis, though the specific target or mechanism for NC-005 remains undisclosed beyond its application in skin health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on NC-005.